精神分裂症中的血脑屏障功能障碍:机制和影响 (综述)
1Department of Psychiatry, The Psychiatric Hospital of Guangzhou Civil Administration Bureau, Guangzhou, Guangdong 510430, P.R. China.
International journal of molecular medicine
|July 25, 2025
概括
血脑屏障 (BBB) 功能障碍越来越多地与精神分裂症的发展和恶化有关. 准BBB可能为精神分裂症提供新的治疗策略,提高治疗效率.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 生物医学科学 生物医学科学
背景情况:
- 精神分裂症是一种复杂的精神疾病,对有效治疗的需求仍未得到满足.
- 新出现的证据表明,血脑屏障 (BBB) 在精神分裂症病理生理学中起着关键作用.
研究的目的:
- 审查和整合目前关于BBB功能障碍在精神分裂症中的作用的发现.
- 探索将BBB功能障碍与精神分裂症联系在一起的机制.
- 讨论潜在的针对BBB的治疗干预措施.
主要方法:
- 综合性文献综述,整合了来自生物化学标记物,神经成像,遗传学研究和实验模型的数据.
- 分析包括脑血流,神经炎症和神经递质系统在内的机制.
- 讨论治疗策略和临床影响.
主要成果:
- BBB功能障碍与精神分裂症的发展和进展有关.
- 机制包括脑血流中断,增强的神经炎症和改变的神经递质系统.
- BBB功能障碍有助于精神分裂症的病理生理学.
结论:
- BBB功能障碍是精神分裂症的一个重要因素.
- 准BBB为新的治疗策略提供了一个有希望的途径.
- 针对BBB的干预措施可以提高药物的疗效,减少精神分裂症治疗中的副作用.
更多相关视频
相关概念视频
The Blood-brain Barrier
48.8K
Overview
48.8K
Biological Causes of Schizophrenia
149
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
149
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
967
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
967
Psychological and Sociocultural Causes of Schizophrenia
189
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
189
Schizophrenia
226
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
226
Factors Affecting Drug Distribution: Physiological Barriers
332
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
332


